-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TFSlRiKmrViAUIkNc6BMbO39zxSOhLPeYyJ0kHxQpEQhXzi+KB/1YloC5FfDy1sK X3uNoc7dcXbe8DoVGr8qqQ== 0000849043-05-000039.txt : 20050611 0000849043-05-000039.hdr.sgml : 20050611 20050525161036 ACCESSION NUMBER: 0000849043-05-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050523 FILED AS OF DATE: 20050525 DATE AS OF CHANGE: 20050525 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROGEN CORP CENTRAL INDEX KEY: 0000849043 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222845714 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 2034888201 MAIL ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUTCHISON ALAN CENTRAL INDEX KEY: 0001131147 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 05857009 BUSINESS ADDRESS: STREET 1: NEUROGEN CORP STREET 2: 35 NORTHEAST INDUSTRIAL ROAD CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 2033153020 MAIL ADDRESS: STREET 1: NEUROGEN CORP STREET 2: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-05-23 0000849043 NEUROGEN CORP NRGN 0001131147 HUTCHISON ALAN 35 NE INDUSTRIAL RD. BRANFORD CT 06405 0 1 0 0 Exec VP Discovery Research Common Stock 2005-05-23 4 O 0 15000 7.01 D 85000 D Common Stock 2005-05-24 4 S 0 7500 6.75 D 77500 D Common Stock 2005-05-23 4 A 0 1539 6.86 A 7341 I By 401K Plan The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2005. Between January 1, 2005 and May 23, 2005 the reporting person acquired 1,539 shares of common stock under the Neurogen Corporation 401(k) plan. The information in this report is based on a plan statement dated as of 5/23/2005. /s/Stephen R. Davis, by power of attorney 2005-05-25 EX-24 2 hutchison.htm 
                  POWER OF ATTORNEY









 The undersigned hereby appoints Stephen R. Davis, EVP

and Chief Business Officer of Neurogen Corporation, his or her

attorney-in-fact and agent in any and all capacities to execute

for and on his or her behalf filings with the Securities and

Exchange Commission on Forms 3, 4 or 5 pursuant to Section 16

of the Securities and Exchange Act of 1934, as amended, to the

extent that such filings relate to the undersigned's status as

a director or officer of Neurogen Corporation.  The undersigned

further appoints Stephen R. Davis his or her attorneyin fact

and agent to execute any and all amendments to such filings as

such attorney-in-fact and agent deems appropriate.  The

undersigned hereby grants to such attorney-in-fact and agent

full power and authority to do and perform each and every act

necessary or desirable as the undersigned could do in person,

hereby ratifying and confirming all that such attorney in fact

and agent may lawfully do or has done by virtue hereof.



This Power of Attorney shall become effective as of February 12, 2001.





/s/ ALAN HUTCHISON

___________________________

Alan Hutchison
-----END PRIVACY-ENHANCED MESSAGE-----